GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Regencell Bioscience Holdings Ltd (NAS:RGC) » Definitions » Total Receivables

RGC (Regencell Bioscience Holdings) Total Receivables : $0.00 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Regencell Bioscience Holdings Total Receivables?

Regencell Bioscience Holdings's Total Receivables for the quarter that ended in Dec. 2024 was $0.00 Mil.


Regencell Bioscience Holdings Total Receivables Historical Data

The historical data trend for Regencell Bioscience Holdings's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regencell Bioscience Holdings Total Receivables Chart

Regencell Bioscience Holdings Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Total Receivables
Get a 7-Day Free Trial - 0.01 0.03 0.06 0.15

Regencell Bioscience Holdings Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.06 - 0.15 -

Regencell Bioscience Holdings Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables


Regencell Bioscience Holdings Total Receivables Related Terms

Thank you for viewing the detailed overview of Regencell Bioscience Holdings's Total Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Regencell Bioscience Holdings Business Description

Traded in Other Exchanges
N/A
Address
29 Leighton Road, 9/F Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.